Question 1

How many institutions own BGLC stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BGLC shares is 2, representing 0.53% of the company's common stock.

Question 2

Who are the major shareholders selling BioNexus Gene Lab Corp. stock?

Accepted Answer

DRW SECURITIES, LLC, in the last quarter, reduced its stake in BGLC by -100% restricting it's holding to 0 shares of worth nearly -. N/A also lessened N/A of the BGLC shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned BGLC shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying BGLC stock?

Accepted Answer

As per its latest 13F filing, UBS GROUP AG increased its stake in BGLC by 100% in the last quarter. The institutional holder raised its holding to 231 shares having worth more than $495.00. WELLS FARGO & COMPANY/MN also added 100% more shares of BGLC to its portfolio, raising its holding to 1 shares of worth $2.00. N/A also increased its BGLC shares holding by N/A which brought its holding to - shares worth -.

Question 4

BGLC's major insiders: who are they?

Accepted Answer

The insider with the most stakes in BGLC is N/A , N/A at the company. Additionally, BGLC stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell BGLC stock?

Accepted Answer

Company executives, directors, and other insiders own 51.11% percent of BioNexus Gene Lab Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which BGLC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased BGLC stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which BioNexus Gene Lab Corp. insiders have bought stock, totalling 0 shares

Question 7

How much of BGLC does insiders own?

Accepted Answer

Around 0 BioNexus Gene Lab Corp. shares are held by insiders, which represents about 51.11% of BGLC stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

BGLC N/A, N/A holds the largest portfolio of the company's shares. BGLC shares owned by N/A total nearly -.

Question 9

Which institution holds the most shares in BGLC?

Accepted Answer

DRW SECURITIES, LLC is the largest institutional owner in BGLC which holds 0 shares worth - or 0% of the total BGLC shares outstanding followed by UBS GROUP AG with ownership of 231 shares representing 0.01% of the BGLC ownership. WELLS FARGO & COMPANY/MN is the third largest stakeholder with 1 shares or 0% of the ownership worth more than $2.00.

Question 10

Is BioNexus Gene Lab Corp. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BGLC is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on BGLC's shares?

Accepted Answer

Number of BGLC shares short is 22.28K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding BGLC shares are there?

Accepted Answer

As of today, 2.42M shares of BGLC are outstanding.

Question 13

Is there many float in BGLC stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BGLC has 1.76M shares in float.

Question 14

BGLC short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BGLC is 0.81.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	DRW SECURITIES, LLC	0%	0	-	-47.83K	-100.00%
Mar 31, 2026	UBS GROUP AG	0.01%	231	495	231	+100.00%
Mar 31, 2026	WELLS FARGO & COMPANY/MN	0%	1	2	1	+100.00%

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	DRW SECURITIES, LLC	0%	0	-	-47.83K	-100.00%
Mar 31, 2026	UBS GROUP AG	0.01%	231	495	231	+100.00%
Mar 31, 2026	WELLS FARGO & COMPANY/MN	0%	1	2	1	+100.00%

BGLC Stock Ownership Breakdown

BioNexus Gene Lab

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions